• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

DEAR MR. NAITO....

Quote




Dear Mr. Naito,

This place is a mess. I do not know anyone here who is happy. Our VP of sales has zero oncology experience. Eisai has become equivalent to hostile work environment, fear and intimidation, incompetence, favoritism, and ……

We want change. Please intervene.

Thank you.
 




Anonymous said:
Dear Mr. Naito,

This place is a mess. I do not know anyone here who is happy. Our VP of sales has zero oncology experience. Eisai has become equivalent to hostile work environment, fear and intimidation, incompetence, favoritism, and ……

We want change. Please intervene.

Thank you.
Click to expand...

Well said.

Mr. Naito: The environment in the home office is also chaotic and most certainly hostile. Your employees are disgruntled, checked-out and indifferent to not only your HHC mission (which has become a JOKE) but also your leaders are NOT following the Eisai values. The companies culture has deteriorated to a point where recovery is not possible. YOU are accountable to take action and make the tough decisions regarding the U.S. senior leadership. They have run the company into the ground needlessly and are stealing money from YOU every single day.
 




Anonymous said:
Dear Mr. Naito,

This place is a mess. I do not know anyone here who is happy. Our VP of sales has zero oncology experience. Eisai has become equivalent to hostile work environment, fear and intimidation, incompetence, favoritism, and ……

We want change. Please intervene.

Thank you.
Click to expand...

How would Naito intervene? U.S. is the largest market and the guy is never here. As long as the cash keeps coming he could care less about your petty little complaints. Of course he'll tell you the typical crap next week.
 




Pasted from another thread on Eisai's board.
-----------------------------------------------

We are dealing with promoted primary care employees that are in support positions for oncology management and the sales force that have no idea what they are doing. I am not saying all, but a significant number. From personal experience it is obvious that a number of the people above are clueless. The reps laugh among themselves about personal stories of incompetance and lack of initiative when dealing with them. It makes the field sales force's jobs much more difficult as standard requests for assistance are inadequite at best.

Launching Halaven is important to Eisai. Primary care management who are lacking in knowledge of oncology are further compounding the situation by promoting many without the experience or initiative to get the job done. It is putting the company at risk, which means also the jobs of many within the organization. The situation we are putting ourselves in is not necessary. Someone please wake up before more damage is done. OB seems like a nice guy from what I know of him, but I know a lot of people that don't know anything about oncology that are nice.

Japan, respectfully, you have big problems that need to be taken care of quickly. Halaven could have been much better to this point with leadership with a proven track record in oncology. If the current group was getting the job done I would not post, but sadly it is not happening. When problems arise they ask for more spread sheets. That is not how real leadership responds. It is only a sign of bewilderment, fear and despiration, because they don't know how to address the problems...just shuffle some more data so they look like they are doing something.
 




Anonymous said:
Pasted from another thread on Eisai's board.
-----------------------------------------------

We are dealing with promoted primary care employees that are in support positions for oncology management and the sales force that have no idea what they are doing. I am not saying all, but a significant number. From personal experience it is obvious that a number of the people above are clueless. The reps laugh among themselves about personal stories of incompetance and lack of initiative when dealing with them. It makes the field sales force's jobs much more difficult as standard requests for assistance are inadequite at best.

Launching Halaven is important to Eisai. Primary care management who are lacking in knowledge of oncology are further compounding the situation by promoting many without the experience or initiative to get the job done. It is putting the company at risk, which means also the jobs of many within the organization. The situation we are putting ourselves in is not necessary. Someone please wake up before more damage is done. OB seems like a nice guy from what I know of him, but I know a lot of people that don't know anything about oncology that are nice.

Japan, respectfully, you have big problems that need to be taken care of quickly. Halaven could have been much better to this point with leadership with a proven track record in oncology. If the current group was getting the job done I would not post, but sadly it is not happening. When problems arise they ask for more spread sheets. That is not how real leadership responds. It is only a sign of bewilderment, fear and despiration, because they don't know how to address the problems...just shuffle some more data so they look like they are doing something.
Click to expand...

stop complaining. complaining is not hhc material.
 




Mr. Naito:

Humbly request an explanation at the national POA regarding the strategy behind investing such a significant amount of cash, $50M, plus valuable resources, on Arena Pharmaceuticals' obesity drug? What in the world were you thinking? Or, are you letting the fools in business development lead you into such preposterous business deals?
 




Anonymous said:
Mr. Naito:

Humbly request an explanation at the national POA regarding the strategy behind investing such a significant amount of cash, $50M, plus valuable resources, on Arena Pharmaceuticals' obesity drug? What in the world were you thinking? Or, are you letting the fools in business development lead you into such preposterous business deals?
Click to expand...

$50m is chump change for a drug that could easily be a $1b a year drug. But you're just a rep. You wouldn't be able to think beyond the $15 a month carwash expense.
 








Dear Mr. Nato,

There is a reign of terror in Eisai conducted by the leadership. We are unhappy. This is the worst pharma company I have ever worked for. At least 80% of the sales force would tell you exactly I just stated if there was no threat of retaliation.
 




























Anonymous said:
Math is not your strong point i see. I'm not sure if you have any strong points or if you'll be able to understand basic math but I'll try. Spend $50m in hopes of getting a $1B drug. See how that works.
Click to expand...

Your point would carry more weight if there was not such a dismal history of spending 'minimal' sums for potentially huge gains.
 




Anonymous said:
Your point would carry more weight if there was not such a dismal history of spending 'minimal' sums for potentially huge gains.
Click to expand...

True. Probably a defensive, not to mention, illogical, response from the usual incompetent manager who's worried about someone reading these posts. Business development has it's head up it's ass hole on Lorcaserin. Good luck with that investment.
 












Top Bottom
Back
Quote